Spinnaker Biosciences, Inc.
Nano porous silicon particles for controlled release drug delivery for the treatment of ocular diseases such AMD and for application to oncology
Funding history
About Spinnaker Biosciences, Inc.
How much funding has Spinnaker Biosciences, Inc. raised?
Spinnaker Biosciences, Inc. has raised $667K in total funding. The most recent round was Series A.
Where is Spinnaker Biosciences, Inc. headquartered?
Spinnaker Biosciences, Inc. is headquartered in Solana Beach, CA.
What does Spinnaker Biosciences, Inc. do?
Nano porous silicon particles for controlled release drug delivery for the treatment of ocular diseases such AMD and for application to oncology
What problem does Spinnaker Biosciences, Inc. solve?
Delivering therapeutic payloads in a controlled, sustained way requires a biocompatible, biodegradable delivery vehicle that can carry a wide range of drugs.
What's Spinnaker Biosciences, Inc.'s solution?
Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite particles engineered as controlled-release drug delivery vehicles.
What makes Spinnaker Biosciences, Inc. different?
A reproducible manufacturing method producing a porous 'nano-sponge' with a dissolution profile that matches the drug release profile, plus self-indicating residual life.
What makes Spinnaker Biosciences, Inc. notable?
Co-founded by Michael Sailor and William Freeman; its porous-silicon materials research has drawn funding from the U.S. Department of Health and Human Services.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.